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Although acute renal failure, caused either byrenal ischemia or nephrotoxic agents, is usually
characterized by oliguria, a severe fall in glomerular filtration rate, and a fall in renal blood
flow, some patients and experimental models display a non-oliguric pattern ofrenal injury. The
present study was designed to evaluate the mechanism of preservation ofhigh urinary flow rate
under this condition.
Following the administration of the aminoglycoside gentamicin to rats for five days, a
decrease in concentrating ability was demonstrated, caused by impaired vasopressin-mediated
water transport. Further treatment resulted in a fall in CintO 15 percent of control, although
RBF was reduced to only 67 percent of control, and urine flow rate rose above control levels.
Induction of acute renal failure with dichromate was associated with variable high or low
urinary flow rates according to pre-injury intake of sodium. Urine volume correlated directly
with cortical blood flow.
These data suggest that the non-oliguric pattern of acute renal injury is caused by preserva-
tion of cortical perfusion in the setting of severe tubular injury.
Acute renal failure (ARF), caused either by renal ischemia or nephrotoxic agents,
is typically characterized by oliguria, a severe reduction in glomerular filtration rate
(GFR), and a variable fall in renal blood flow (RBF). The urine is isotonic and
tubular reabsorption of sodium is markedly impaired. Recent studies report,
however, that an increasing proportion of patients with acute renal failure display a
non-oliguric pattern of renal injury [1,2]. Nephrotoxins, and especially aminoglyco-
side antibiotics, are cited as important etiologic factors in many of these cases. Since
the mechanism responsible for a high urinary flow rate in the presence ofacute renal
failure has not been elucidated, the present study was performed to analyze the
characteristic features of this pattern of renal injury in an experimental model of
gentamicin-induced non-oliguric renal failure. The aminoglycoside gentamicin has a
well-documented nephrotoxic potential [3], and produces in both humans and
experimental animals a dose-related progressive acute renal failure which is typically
non-oliguric [4]. The possible role of hemodynamic factors in the mechanism ofnon-
oliguric ARF was also investigated in another model ofnephrotoxic ARF induced by
dichromate. Since urinary flow rate can be modulated by dietary sodium intake in
animals with dichromate-induced ARF [5], cortical bloodflow was correlated with
urinary flow rate in this model of ARF as well as in gentamicin-treated animals.
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Experiments were performed in male Sprague-Dawley rats weighing 180 to 250 g
at the initiation of drug administration. All animals were fed standard Purina rat
chow and allowed ad-lib access to tap water.
GENTAMICIN-INDUCED ACUTE RENAL FAILURE
Experimental animals were given subcutaneous injections of gentamicin sulfate
(Garamycin, Schering Corp.) at a dose of 80 mg/kg body weight per dayfor up to 12
days. Control animals were treated with an approximately equal volume (0.5 ml) of
0.15 M NaCl during similar time intervals.
Determination of Urine Flow Rate, Concentrating Ability,
and Free Water Clearance
Animals were placed in metabolic cages to collect total urine volume under oil
without fecal contamination during consecutive 24-hour intervals. After an adapta-
tion period of three days, treatment with either gentamicin or 0.15 M NaCl was
begun. Daily urine volumes were determined in a graduated cylinder.
To determine urinary concentrating ability, conscious control and experimental
animals were studied one day before, on the day ofinitiation oftreatment, and on the
fifth and tenth day after treatment with subcutaneous gentamicin. Animals were
placed in metabolic cages, deprived of access to water, and administered 0.5 units of
aqueous vasopressin (Pitressin, Parke-Davis) subcutaneously on study days. One
hour following administration of vasopressin, animals were induced to void by light
suprapubic pressure and urine was collected quantitatively for two subsequent hours,
at which time voiding was again induced. The osmolarity of the urine was measured
with a Wescor-Vapor pressure osmometer (Model 5100 B, Wescor, Inc., Logan,
Utah).
To examine the mechanism(s) ofthe observed impairment in concentrating ability
further, free water clearance was determined in additional conscious experimental
animals after five days of treatment with gentamicin and in control animals. A water
diuresis was produced by the oral load of 5.0 ml water/ 100 g body weight given by
gavage, under light ether anesthesia. After induced voiding, animals were placed in
metabolic cages and urine was collected during two consecutive 60-minute intervals.
At the end of each interval, voiding was induced. At the termination of the final
collection, a sample of aortic blood was obtained and animals were sacrificed. Urine
and plasma was analyzed for osmolarity (Wescor-Vapor pressure osmometer).
Determination of GFR, RBF, and Electrolyte Excretion
Anesthesia was induced with Inactin (Promonta, Hamburg) at a dose of 40-120
mg/kg body weight to produce a similar level of anesthesia in all groups. Animals
were placed on a heated board; a tracheostomy was performed and the bladder and
one external jugular vein were cannulated with PE-50 tubing. A left carotid arterial
catheter and femoral artery catheter were inserted.
After replacement ofsurgical fluid losses with 0.15 M NaCl at one percent ofbody
weight, a priming dose of 10,uCi of inulin-methoxy-3H (New England Nuclear Corp.)
was given intravenously and was followed by a sustaining dose of l0MCi in a volume
of 1.2 ml/hour of 0.15 M NaCl. After 45 minutes of equilibration, timed urine
collections at ten-minute intervals were begun and tail blood samples obtained at the
midpoint of each collection. At the termination ofthefinal urine collection, a sample
of blood was obtained from the left renal vein with a 25-gauge needle.
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After completion of the three clearance periods, total and regional blood flow were
determined using radioactive microspheres as previously described [6]. Microspheres,
15 ± 2,u in diameter and labeled with Sr85, were dissolved in 10 percent dextran
containing three drops of Tween 80. Microspheres were mixed for one minute with
an ultrasonic dismembrator (Artek Systems Corp., Farmingdale, N.Y.) prior to
injection. During injection of 0.2 ml (approximately 120,000 microspheres) of the
mixture into the carotid artery catheter, blood was simultaneously withdrawn for one
minute from the femoral artery at a fixed rate of 1.03 ml/min. The animals were
sacrificed, the kidneys removed, the capsule stripped, and a midsagittal section of
each kidney was made. Each kidney was placed on a microtome and the outer 0.5 mm
of cortex was excised, weighed, and labeled "OC." The remainder of the kidney was
weighed and the sum ofthe weights ofthe two outer cortical slices plus the remainder
was calculated as total kidney weight ("TC"). The activity ofthe isotope in each outer
cortical slice, as well as the remainder, was determined in a gamma counter(Beckman
Instruments, NJ), and the sum of the activities for each kidney was determined.
The radioactivity of inulin-methoxy-3H in plasma and urine was determined in a
liquid scintillation counter (Tri-carb). The concentration of sodium and potassium
was measured with a flame photometer with an internal standard. Standard formulae
were used to calculate Ci,r and the urinary excretion ofelectrolytes. Renal blood flow
was determined by two methods for control and five-day experimental animals: (a)
RBF = RPF/ 1 - Hct, where RPF = Cin/Ei,. The value Ein was determined from
Ai, - Vin /Ai., where A and V represent arterial and renal venous concentrations of
inulin. (b) RBF = Sr85 CPM whole kidney/CPM femoral arterial blood x 1.03
ml/min (the femoral arterial flow rate). Proportional flow to the outer cortex
(OT/TC ratio) was calculated as CPM/g outer cortex + CPM/g whole kidney. In the
ten- and 12-day experimental groups, since Ei was markedly reduced and RBF could
not be accurately estimated by this method, only the microsphere method was
employed.
Morphologic Correlates ofFunctional Abnormalities
Additional groups of control animals and experimental animals treated with
gentamicin for five days were anesthetized with Inactin. The chest was entered via a
transverse incision below the sternum and in vivo perfusion and fixation was
performed with a catheter positioned in the aorta. For renal cortical histologic
sampling, a 350 mM NaCl in 3 percent dextran solution was first flushed through the
catheter and followed by Karnovsky's fixative [7] diluted 1:3 with 0.1M sodium
cacodylate buffer and 175 mM NaCl in 3 percent dextran. For medullary sampling,
the vasculature was flushed with 550 mM NaCl in 3 percent dextran followed by the
same fixature and buffer in 350 mM NaCl plus 3 percent dextran. Samples ofcortical
and medullary tissue were placed in Karnovsky's fixative, washed in cacodylate
buffer, and post fixed in osmium tetroxide. After embedding in Epon, sectioning was
performed on an LKB ultratome III and grids were scanned and photographed in
Zeiss SM9S electron microscope.
DICHROMATE-INDUCED ACUTE RENAL FAILURE
To compare the findings in aminoglycoside ARF to another model ofnon-oliguric
nephrotoxic ARF, animals were offered either food containing no sodium and tap
water (low-salt group) or regular Purina Chow and 0.15 m NaCl to drink (high salt
group). After two weeks of dietary preparation, each group was divided into
experimental animals, which were treated with potassium dichromate in a dose of 15
275mg/kg (subcutaneously) and control animals which received 0.15 M NaCl in an
equivalent volume of 0.1 cc.
Twenty-four hours after treatment, measurement of GFR, RBF, renal blood flow
distribution, and urinary flow rate were made using the same methods described
above.
Results are expressed as the mean ± SEM and the Student's test was used to
compare groups of animals.
RESULTS
Gentamicin-Induced Acute Renal Failure
a. Urinary flow rate, concentrating ability, free water clearance:
The administration ofgentamicin caused a progressive increase in urinaryflow rate
(Fig. 1). By day seven after initiation of treatment, urine volume was significantly
increased in the gentamicin treated animals.
The upper panel of Fig. 2 displays the results of maximum concentrating ability
following exogenous vasopressin administration. Mean urine osmolarity on day zero
was 1,829 + 100 mOsm/kg H20 and was not significantly different following the
administration of gentamicin for one day. Following five days oftreatment, however,
means osmolarity decreased by 35 percent to 1,183 ± 168 (p < 0.005) and by day ten
decreased further to 600 ±44 mOsm/kg H20 (p < 0.001).
As shown in the lower portion ofFig. 2, CH2O , at comparable levels ofdistal solute
delivery (CNa+ + C H2O), was similar in both control and experimental animals
treated for five days. Since Ci. was similar in controls and the group treated with
gentamicin for five days, these values were not factored byCin. It is important to note
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FIG. 1. Daily urine volume during gentamicin treatment (80 mg/kg/day).
The arrow represents the first day of drug injection. Values represent mean
± SEM (n = 12-18 animals).
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FIG. 2. Upper panel. Maximum urinary concentrating ability following
vasopressin administration. Day 0 represents first day of drug injection. Values
represent mean ± SEM (n = 10 animals). Lowerpanel. Free water clearance
versus distal sodium delivery. Open circles represent control animals (n = 5
animals); closed circles represent animals treated with gentamicin for five days
(n 5 animals); C H20 and CNa + C H20 in ml/hr.
UOsm (132.4 ± 25.4 mOsm/kg H20) in experimental animals were not statistically
different from control.
b. GFR, RBF, and electrolyte excretion:
The results of determination of Cin, RBF, V, and sodium excretion are shown in
Table 1. Control animals treated with subcutaneous injections of saline for five, ten,
or 12 days showed no differences in regard to parameters of renal function and are
listed collectively.
At five days oftreatment with gentamicin, there was no significant change in Cin or
FENa and, although V was increased 50 percent the rise was statistically insignificant.
However, after ten days of treatment, experimental showed a 48 percent reduction
in Cimn from the control value of 1,158 + 60 Ml/min/ 100 g body weight to
602 ± 130,l/min/ 100 g body weight (p < 0.01). Cim was further reduced to about 15
percent of control values (176 ± 47 ,ul/min/ 100 g body weight) in animals treated for
12 days. These reductions in Cin were associated with large and significant increases
in urine flow rate to 4.95 ± 0.76,ul/min/ 100 g body weight at ten days (p < 0.01) and
7.56 ± 1.77 Al/min/ 100 g body weight at 12 days (p < 0.01). FENa was also markedly
increased on days ten and 12 of treatment.
Gain in bodyweight was not significantly different from control (6.1 ± 0.4g/day) in
gentamicin-treated animals through the fifth day of treatment. Beyond that time,
however, body weight fell in association with severe renal failure.
Mean values of total renal blood flow (RBF) and cortical blood flow distribution
(OC/TC) are also shown in Table 1. The values of total renal blood flow determined
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Effect of Gentamicin on Parameters of Renal Function
Gentamicin Treatment
Control 5 Days 10 Days 12 Days
N 12 7 11 10
Final Body weight (g) 294 i 9 260 X 16 220 X 11* 228 11*
V (1l/min/100gBW) 1.99 A 0.25 3.29 i 1.20 4.95 f 0.76* 7.56 A 1.77*
Cin (,ul/min/100gBW) 1158 i 60 1130 + 130 602 + 130* 176 4 47*
RBF (ul/min/100gBW) 5979 + 514 4638 + 723 4160 f 480* 3998 f 721+
OC/TC 1.55 + 0.03 1.55 + 0.06 1.59 + 0.05 1.78 i 0.06*
FENa 0.04 + 0.01 0.13 + 0.07 2.16 + 1.00 2.75 ~0.48+
Values represent mean SEM; N indicated the number animals studied. The following symbols
denote a statistical difference compared to the control group; 'p<0.05: *p<0.01.
by the microsphere method did not differ significantly from values estimated by the
clearance and extraction of inulin; results from the microsphere method alone are
shown in the table. Although RBF was not reduced by the fifth day of treatment
compared to the control value 5,979 + 514 ul/min/ 100 g BW, blood flow was reduced
to 70 percent and 67 percent of control on the tenth and twelfth days of treatment,
respectively. Proportional flow to the outer cortex (OC/TC) was not significantly
different from control (1.55 ± 0.03) on days five and ten, but rose above control to
1.78 ± 0.06 on day 12 (p < 0.05).
c. Morphologic correlates of functional abnormalities:
After five days of treatment with gentamicin, proximal tubular cells displayed
prominent alterations of lysosomes and large numbers of "myeloid bodies," as
previously reported [8]. Rare lysosomal myeloid bodies were noted in distal tubular
cells, but never to the extent found in the proximal tubules. There were no other
apparent differences between the control and experimental groups on morphologic
examination.
Dichromate-Induced Acute Renal Failure
Changes in GFR, RBF, and urinary flow rate observed in the animals treated with
potassium dichromate after dietary sodium manipulation are shown in Table 2. In
animals injected with 0.15 M NaCl, Cin RBF, and V were similar in both high-salt
and low-salt groups. Proportional blood flow, however, was reduced in animals on a
sodium-free diet (1.47 ±0.03) compared to the group receiving a high sodium load
(1.63 ± 0.03,p < 0.01).
Twenty-four hours after administration of dichromate, C in was markedly reduced
in both groups of animals to 33 percent and six percent of control values in high and
low sodium groups, respectively. In sodium-deprived animals, RBF fell 75 percent
compared to saline-injected animals and proportional flow to the outer cortex
decreased in association with a significant fall in V. In contrast, both total RBF and
proportional flow to the outer cortex were unaltered in the high-salt intake group,
which was also non-oliguric. In these animals with dichromate-induced ARF
therefore, the preservation of RBF and OC/TC (high-salt group) was associated with
a non-oliguric pattern of ARF whereas a marked reduction in RBF and OC/TC
(low-salt group) was characterized by a more severe fall inCin and an oliguric pattern
of ARF.
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TABLE 2
Effect of Potassium Dichromate on Parameters of Renal Function
High Sodium Low Sodium
Saline-Injected
V, Al/min 4.7 4 0.5 4.5 + 0.5
Cn, Al/min/100gBW 1040 + 50 977 4 60
RBF, Al/min/100gBW 5330 4 310 5970 A 530
Proportional blood 1.63 + 0.03 1.47 4 0.03a
flow OC/TC
Dichromate-Injected
V, jl/min 3.8 + 1.0 1.8 + 0.3ab
Cin, Al/min/100gBW 370 l1OOb 60 + 30-b
RBF, Al/min/100gBW 5260 i 750 1480 X 320a-b
Proportional blood 1.69 + 0.04 1.32 i 0.03a,b
flow OC/TC
Values are mean : SEM
ap<0.01 High Sodium vs. Low Sodium Group
bp<0.01 Saline-Injected vs. Dichromate-Treated Group
DISCUSSION
Over the past decade, the pathophysiology of acute renal failure has received
considerable attention. Primary attention has been focused on the mechanisms
responsible for the reduction in glomerular filtration rate and diminished urine
output [9]. Considerably less emphasis, however, has been given to the mechanisms
involved in non-oliguric acute renal failure, although this type of acute renal failure
has been recognized with increased frequency in clinical reports [1,2]. The present
study was designed to investigate the potential mechanism(s) responsible for high
urine flow rate in two experimental models of non-oliguric acute renal failure.
In animals treated with gentamicin, concentrating ability was impaired on dayfive
of treatment in the absence of changes in glomerular filtration rate, total renal blood
flow, or blood flow distribution. Consequently, thefall in concentrating ability could
not be attributed to a decrease in solute delivery to the loop of Henle or wash out of
the medullary concentrating gradient. Moreover, the concentrating defect was
unlikely to be due to reduced solute reabsorption in the ascending limb, since CH20
was not reduced when solute delivery to the distal nephron was comparable to
control, or by diminished medullary urea concentration due to protein deprivation,
since animals maintained normal weight gain through day five of treatment. In
addition, primary polydipsia seems unlikely since urine flow rate was not signifi-
cantly increased on day five. The present data therefore, suggest that the gentamicin-
induced concentrating defect observed early in the course of treatment was due to
impairment of vasopressin-mediated water movement in the collecting duct system.
Since myeloid bodies were abundant in proximal tubules, but were not prominently
discernable in distal nephron segments on day five, the present study indicates an
apparent dissociation of structure-function relationships in the early phase of this
type of nephrotoxicity.
Treatment with gentamicin for ten and 12 days led to the characteristic features of
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severe impairment in sodium reabsorption, urine flow rate remained high and
actually increased above control values. Despite the severe fall in Cin, total renal
blood flow decreased to only 67 percent of control and proportional blood flow to
the outer cortex rose to levels above control. These data suggest that the high urine
flow rate may be related to the maintenance of relatively high rates of cortical blood
flow at a time when Cin was severely impaired.
Since gentamicin may have a unique action on tubular reabsorption of water,
additional experiments were performed in another model of nephrotoxic ARF to
determine whether high rates of urine flow would also correlate with preservation of
cortical perfusion. Potassium dichromate was chosen as the nephrotoxin since
manipulation of dietary sodium intake has been shown to influence urine flow rate
after induction of injury [5]. Animals on a low sodium diet developed a severe
oliguric ARF associated with a marked fall in total RBF and outer cortical perfusion.
In contrast, in animals on a high sodium diet the fall in Cin to 30 percent of control
was associated with well-maintained urine flow rate and preservation of cortical
perfusion at control levels. Thus, despite treatment with the same nephrotoxin,
marked differences in urine flow rate in this model of acute renal failure were
observed. Animals with non-oliguric dichromate-induced ARF exhibited hemody-
namic changes similar to those observed in gentamicin-treated non-oliguric ARF.
These data therefore suggest that the preservation of cortical perfusion in the
presence of diminished Cin may be a characteristic feature of non-oliguric ARF.
Recent studies have suggested that microspheres are subject to axial streaming
and, thereby, overestimate absolute outer cortical perfusion in the rat [10,11]. In the
present studies, microspheres were used only as an index of outer cortical perfusion,
rather than as a determinant of absolute outer cortical perfusion. Moreover, since
previous studies have demonstrated a preferential increase in vascular resistance in
the outer cortex during acute renal failure [12], it seems likely that axial streaming, if
it were to occur, would favor a redistribution of blood flow away from rather than
toward the outer cortex as found in gentamicin-treated animals. Whether or not
current methodology available for estimating renal blood flow distribution provides
a useful index, it should be recalled that approximately 85 to 90 percent ofblood flow
to the kidney perfuses the cortex. In both models of non-oliguric acute renal failure
studied in these experiments the maintenance of near normal levels of total blood
flow indicates relatively high rates of cortical perfusion.
Previous studies from our laboratory have documented preferential reperfusion of
the outer cortex during the diuretic phase of the recovery from anoliguric ischemic or
toxic acute renal injury and after release of bilateral ureteral occlusion [13,6,14]. In
each of these experimental conditions there was a reduction in C in which was
associated with increased urine output and increased fractional sodium excretion. It
is possible, therefore, the preservation or restoration of cortical perfusion in the
setting of reduced glomerular function and acute tubular injury results inglomerular-
tubular imbalance, which is expressed as a non-oliguric pattern of ARF due to
increased fractional excretion of water and solute.
In conclusion, this study provides data which indicates: (1) gentamicin impairs
vasopressin-induced water transport early in the course of treatment and suggests
that (2) preservation of cortical blood perfusion following nephrotoxic injury is
associated with a non-oliguric pattern of acute renal failure.
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